FdaApplication

ANDA 208429

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCHARTWELL RX SCIENCES LLC
application_typeANDA
approval_date2019-01-17

Products (2)

ProductActive ingredientStrengthDosage form
IMATINIB MESYLATEIMATINIB MESYLATEEQ 400MG BASETABLET;ORAL
IMATINIB MESYLATEIMATINIB MESYLATEEQ 100MG BASETABLET;ORAL

2 products